MSA Pharmacy Hosts Pharmacovigilance Event
In collaboration with the Ministry of Health and Population, the Egyptian Drug Authority (EDA), and Pfizer, the Faculty of Pharmacy at October University for Modern Sciences and Arts (MSA University), under the umbrella of the student activity “Model World Health Organization (mWHO)”, organized a distinguished event titled:
“Pharmacovigilance in Action: From Reporting to Real-World Impact”
The event was held on May 14, 2026, as part of the Faculty’s commitment to enhancing awareness of the role of pharmacovigilance in supporting and advancing the healthcare system.
The event was attended by Dr. Hend Ashour, Head of the Central Administration of Pharmaceutical Affairs at the Ministry of Health and Population.
During the event, the pivotal role of the Egyptian Drug Authority (EDA) in supporting the pharmacovigilance system in Egypt was highlighted. Dr. Mai Gamal Mohamed – Senior PV Inspector, Egyptian Drug Authority (EDA) explained the role of the EDA in regulating the pharmacovigilance system in Egypt, reviewing adverse event reporting mechanisms, signal detection processes, and the role of regulatory authorities in supporting patient safety and promoting the safe use of pharmaceutical products.
In addition, Dr. Mahmoud Osama Ibrahim – Senior PV Specialist, Egyptian Drug Authority (EDA) addressed the practical and applied aspects of the Egyptian pharmacovigilance system, highlighting the role of analyzing drug safety reports and making regulatory decisions based on pharmacovigilance data.
Furthermore, Dr. Hadeer Rostom – Chair, ISoP Egypt Chapter | Membership Coordinator, International Society of Pharmacovigilance (ISoP) discussed advanced concepts in pharmacovigilance sciences, ranging from the fundamentals of signal detection to risk management plans, while shedding light on the role of the World Health Organization and Egypt’s participation in the global pharmacovigilance network.
Moreover, Dr. Amira Onsi – Safety Lead Egypt, Levant, Iraq and Iran, Pfizer addressed Pfizer’s role in supporting drug safety systems through global databases, case analysis, signal verification, and the importance of collaboration with various regulatory authorities.
Dr. Mohamed El Hawary – Vaccine Safety Officer, Ministry of Health also discussed the role of the Ministry of Health in monitoring vaccine safety and promoting the culture of adverse event reporting, emphasizing the importance of raising both community and professional awareness regarding pharmacovigilance.
Additionally, Dr. Aya Anis – PV Vendor & Operations Manager, Baupharma highlighted the role of outsourcing companies in supporting pharmacovigilance systems and their contribution to managing and monitoring drug safety reports while enhancing the efficiency of safety-related operations.
The Faculty emphasized that this event comes as part of its ongoing efforts to strengthen collaboration with the Egyptian Drug Authority, the Ministry of Health and Population, and international pharmaceutical companies, while connecting students with modern practical applications, contributing to the preparation of pharmaceutical professionals capable of supporting healthcare systems and patient safety both locally and internationally.
